首页> 外文期刊>American journal of Alzheimer's disease and other dementias >Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer's Disease: A Meta-analysis of Randomized Clinical Trials
【24h】

Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer's Disease: A Meta-analysis of Randomized Clinical Trials

机译:传统非甾体类抗炎药在阿尔茨海默氏病中的作用:随机临床试验的荟萃分析

获取原文
获取原文并翻译 | 示例
       

摘要

The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in prevention of Alzheimer's disease (AD) has been evaluated in many studies. We performed a meta-analysis to summarize the existing evidence on the relation between use of classical NSAIDs and AD. Randomized controlled trials (RCTs) evaluating the role of classical NSAIDs in AD was searched using different search engines. The RCTs in patients who had the degree of AD measured on Mini-Mental State Examination (MMSE) or AD Assessment Scale-Cognitive subscale (ADAS-cog) were included in the study. The RCTs and data (AD scores) were independently assessed by 2 reviewers, and data were included in meta-analysis only after a common consensus was reached. The pooled results from the ADAS-cog and MMSE scores failed to show any difference between the treatment and the placebo groups as opposed to findings from some observational studies. However, in view of heterogeneity of results, there is a need to conduct more RCTs to arrive at confirmatory findings.
机译:在许多研究中已经评估了非甾体抗炎药(NSAIDs)在预防阿尔茨海默氏病(AD)中的作用。我们进行了荟萃分析,总结了有关使用经典NSAID与AD之间关系的现有证据。使用不同的搜索引擎搜索了评估经典NSAID在AD中的作用的随机对照试验(RCT)。该研究纳入了具有通过轻度精神状态检查(MMSE)或AD评估量表-认知子量表(ADAS-cog)测量的AD程度的患者的RCT。 RCT和数据(AD评分)由2位审阅者独立评估,并且只有在达成共识后,数据才被纳入荟萃分析。 ADAS-cog和MMSE评分的汇总结果未能显示出治疗组与安慰剂组之间的任何差异,这与某些观察性研究的结果相反。但是,鉴于结果的异质性,有必要进行更多的随机对照试验以得出证实性结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号